Insider Transactions

Date	Name	Title	Type	Shares Traded	Price Range
Jun 4, 2010	graziano chane	Officer	Acquisition (Non Open Market)	133,600	n/a
Jun 4, 2010	Green, David	Officer	Acquisition (Non Open Market)	133,600	n/a
Jun 4, 2010	luscinski susan m	Officer	Acquisition (Non Open Market)	66,800	n/a
Jun 4, 2010	mcnaughton thomas	Officer	Acquisition (Non Open Market)	66,800	n/a
Nov 12, 2009	luscinski susan m	Officer	Option Execute	98,550	1.05
Sep 16, 2009	Lewis, Earl R.	Director	Buy	5,534	3.75
Sep 15, 2009	Lewis, Earl R.	Director	Buy	14,466	3.69 - 3.73
Sep 15, 2009	Uveges, George	Director	Buy	2,500	3.70
Apr 1, 2009	skystone advisors llc	Beneficial Owner (10% or more)	Disposition (Non Open Market)	2,746,988	n/a
Mar 26, 2009	skystone advisors llc	Beneficial Owner (10% or more)	Sell	5,860	3.00
Mar 24, 2009	skystone advisors llc	Beneficial Owner (10% or more)	Sell	1,300	3.10
Mar 12, 2009	skystone advisors llc	Beneficial Owner (10% or more)	Sell	7,958	2.75
Mar 5, 2009	Green, David	Officer	Automatic Buy	453	2.49
Mar 3, 2009	Green, David	Officer	Automatic Buy	687	2.48 - 2.49
Mar 2, 2009	Green, David	Officer	Automatic Buy	2,587	2.49
Feb 27, 2009	Green, David	Officer	Automatic Buy	9,800	2.40 - 2.47
Feb 26, 2009	Green, David	Officer	Automatic Buy	4,789	2.49
Feb 3, 2009	Green, David	Officer	Automatic Buy	100	2.49
Feb 2, 2009	Green, David	Officer	Automatic Buy	722	2.47 - 2.49
Jan 27, 2009	Green, David	Officer	Automatic Buy	2,100	2.45 - 2.49
Showing 1-20 of 79 transactions Page: 1 2 3 4  See Next 20

Stock transaction information provided by EDGAR Online. Harvard Bioscience, Inc. makes no representation or warranty with respect to any of the information contained herein, takes no responsibility for supplementing, updating or correcting any such information and shall have no liability with respect to any such information. This listing does not include derivatives, such as stock option grants or shares purchased through an employee stock purchase plan. For recent transactions, including derivative transactions, see our Section 16 SEC filings page.

Disclaimer:
The information contained within this and other Harvard Bioscience Web pages should be deemed accurate and current as of the date of the most recent update, or if no update information has been provided, the date of issuance. Harvard Bioscience assumes no responsibility for any misincurrances or misstatements which occur as the result of the reading of dated material. Users are strongly encouraged to check dates of issuance and most recent update of any information contained within, or linked to, Harvard Bioscience’s web site. For Harvard Bioscience’s most current information please reference Harvard Bioscience public filings with the Securities and Exchange Commission located at http://www.sec.gov.